Several other equities analysts also recently issued reports on NMC. Jefferies Financial Group reduced their price objective on shares of NMC Health from GBX 2,077 ($27.14) to GBX 1,986 ($25.95) and set an “underperform” rating on the stock in a research note on Tuesday, July 9th. Societe Generale reaffirmed a “buy” rating on shares of NMC Health in a research note on Tuesday, August 27th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 3,600 ($47.04) price target on shares of NMC Health in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of GBX 3,740.20 ($48.87).
Shares of LON NMC opened at GBX 2,934 ($38.34) on Monday. The company has a market cap of $6.13 billion and a PE ratio of 22.74. NMC Health has a 12 month low of GBX 1,773.50 ($23.17) and a 12 month high of GBX 3,984 ($52.06). The company has a debt-to-equity ratio of 165.90, a current ratio of 1.70 and a quick ratio of 1.43. The company has a 50-day simple moving average of GBX 2,261.29 and a 200-day simple moving average of GBX 2,448.81.
NMC Health Company Profile
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.
See Also: Percentage Gainers
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.